Trial reportBMC family practice2019
Patient-centered communication and shared decision making to reduce HbA1c levels of patients with poorly controlled type 2 diabetes mellitus - results of the cluster-randomized controlled DEBATE trial.
Trial report in BMC family practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Shared Decision-Making in Cardiovascular Risk Factor Management: A Systematic Review and Meta-Analysis.JAMA network open · 2024Pooled it
- Pooled it
- HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial.BMC primary care · 2023Trial
- Shared decision making and patient-centeredness for patients with poorly controlled type 2 diabetes mellitus in primary care-results of the cluster-randomised controlled DEBATE trial.BMC family practice · 2021Trial
- Enhancing Type 2 Diabetes Management Involving Healthcare Professionals in Primary Care.Healthcare (Basel, Switzerland) · 2026Review
- Patient-physician communication of health and risk information in the management of cardiovascular diseases and diabetes: a systematic scoping review.BMC medicine · 2025Article
- Burden of type 2 diabetes in working-age adults (20-54 years): a GBD 2021 analysis projecting trends to 2035 and exploring the potential benefits of physical activity.Frontiers in public health · 2025Article
- Patient-centered care in diabetes care-concepts, relationships and practice.World journal of diabetes · 2024Review
- Shared decision-making training in general practice: a rapid review.Future healthcare journal · 2023Review
- GPs' perceptions of teaching methods in shared decision-making training: a qualitative study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023Article
- Formative Qualitative Research: Design Considerations for a Self-Directed Lifestyle Intervention for Type-2 Diabetes Patients Using Human-Centered Design Principles in Benin.International journal of environmental research and public health · 2022Article
- Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort.Medicina (Kaunas, Lithuania) · 2022Article
- Reduction of potentially inappropriate medication in the elderly: design of a cluster-randomised controlled trial in German primary care practices (RIME).Therapeutic advances in drug safety · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDoes an intervention designed to foster patient-centered communication and shared decision making among GPs and their patients with poorly controlled type 2 diabetes mellitus reduce the level of HbA1c.
methodsThe DEBATE trial is a cluster-randomized controlled trial conducted in German primary care and including patients with type 2 diabetes mellitus having an HbA1c level of 8.0% (64 mmol/mol) or above at the time of recruitment. Data was measured before intervention (baseline, T0), 6-8 months (T1), 12-14 months (T2), 18-20 months (T3), and 24-26 months (T4) after baseline. Main outcome measure is the level of HbA1c.
resultsIn both, the intervention and the control group the decline of the HbA1c level from T0 to T4 was statistically significant (- 0.67% (95% CI: - 0.80,-0.54%; p < 0.0001) and - 0.64% (95% CI: - 0.78, - 0.51%; p < 0.0001), respectively). However, there was no statistically significant difference between both groups.
conclusionsAlthough the DEBATE trial was not able to confirm effectiveness of the intervention tested compared to care as usual, the results suggest that patients with poorly controlled type 2 diabetes are able to improve their blood glucose levels. This finding may encourage physicians to stay on task to regularly approach this cohort of patients.
trial registrationThe trial was registered at ISRCTN registry under the reference ISRCTN70713571 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.